Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07639723 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Aprepitant to Improve Same Day Discharge for TKA

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The purpose of this research is to study whether adding an FDA approved medication called aprepitant (a medication given to patients like you to reduce or eliminate nausea and vomiting) to the usual treatment to prevent nausea and vomiting given to patients during knee replacement surgery helps more patients go home on the same day of surgery (before midnight) by eliminating nausea and vomiting.
Trial Details
NCT Number NCT07639723
Lead Sponsor Endeavor Health
Collaborators: Heron Therapeutics, Inc. (formerly A.P. Pharma, Inc.)
Conditions
(from sponsor)		 PONV
Related terms Postoperative Nausea and Vomiting
Enrollment 350 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov